Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

Annals of Neurology

Volumn 66, Issue 1, 2009, Pages 11-18

  Florance, Nicole R ^a   Davis, Rebecca L ^b   Lam, Christopher ^a   Szperka, Christina ^a   Zhou, Lei ^b   Ahmad, Saba ^a   Campen, Cynthia J ^a   Moss, Heather ^b   Peter, Nadja ^a   Gleichman, Amy J ^b   Glaser, Carol A ^c   Lynch, David R ^a,b   Rosenfeld, Myrna R ^b   Dalmau, Josep ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Division of Communicable Disease Control   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1 ANTIBODY; METHYLPREDNISOLONE SODIUM SUCCINATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1 ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADOLESCENT; ANTI NMDAR ENCEPHALITIS; ARTICLE; CELL STRAIN HEK293; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DYSAUTONOMIA; DYSKINESIA; DYSTONIA; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HYPOVENTILATION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOTHERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TERATOMA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; SEIZURE; SPEECH DISORDER; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

ADOLESCENT; ANTIBODIES; CELL LINE, TRANSFORMED; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INFANT; MALE; POSTURAL BALANCE; RECEPTORS, N-METHYL-D-ASPARTATE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TRANSFECTION;

EID: 69249106795     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21756     Document Type: Article

References (16)

1. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
2. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008;70:504-511.
3. Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008;79:324-326.
4. Sansing LH, Tuzun E, Ko MW, et al. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007;3:291-296.
5. Tonomura Y, Kataoka H, Hara Y, et al. Clinical analysis of paraneoplastic encephalitis associated with ovarian teratoma. J Neurooncol 2007;84:287-292.
6. Ishiura H, Matsuda S, Higashihara M, et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 2008;71:1921-1923.
7. Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005;58:594-604.
8. Shimazaki H, Ando Y, Nakano I, Dalmau J. Reversible limbic encephalitis with antibodies against the membranes of neurones of the hippocampus. J Neurol Neurosurg Psychiatry 2007;78: 324-325.
9. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
10. Kleinig TJ, Thompson PD, Matar W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008;23:1256-1261.
11. Lewis P, Glaser CA. Encephalitis. Pediatr Rev 2005;26: 353-363.
12. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006;43:1565-1577.
13. Wirtz PW, Nijnuis MG, Sotodeh M, et al. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol 2003;250:698-701.
14. Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 2002;104:359-363.
15. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-1140.
16. Eker A, Saka E, Dalmau J, et al. Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 2008;79:1082-1083.